Literature DB >> 27618780

Impact of lymph node occult metastases in stage I non-small cell lung cancer (NSCLC): what is the evidence?

Giuseppe Marulli1, Marco Mammana1, Federico Rea1.   

Abstract

Entities:  

Year:  2016        PMID： 27618780      PMCID： PMC4999668          DOI： 10.21037/jtd.2016.07.59

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  19 in total

Review 1.  Early stage lung cancer: progress in the last 40 years [corrected].

Authors:  Silvia Novello; Hisao Asamura; Jose Bazan; David Carbone; Peter Goldstraw; Dominique Grunenwald; Umberto Ricardi; Johan Vansteenkiste
Journal:  J Thorac Oncol       Date:  2014-10       Impact factor: 15.609

2.  Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.

Authors:  Fumihiro Shoji; Akira Haro; Tsukihisa Yoshida; Kensaku Ito; Yosuke Morodomi; Tokujiro Yano; Yoshihiko Maehara
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

3.  Pleural cytologies in lung cancer without pleural effusions.

Authors:  S I Kjellberg; C M Dresler; M Goldberg
Journal:  Ann Thorac Surg       Date:  1997-10       Impact factor: 4.330

4.  Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial.

Authors:  Valerie W Rusch; Debra Hawes; Paul A Decker; Sue Ellen Martin; Andrea Abati; Rodney J Landreneau; G Alexander Patterson; Richard I Inculet; David R Jones; Richard A Malthaner; Robbin G Cohen; Karla Ballman; Joe B Putnam; Richard J Cote
Journal:  J Clin Oncol       Date:  2011-10-11       Impact factor: 44.544

5.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

6.  Early recurrence after surgical resection in patients with pathological stage I non-small cell lung cancer.

Authors:  R Kawachi; H Tsukada; Y Nakazato; H Takei; G Furuyashiki; Y Koshi-ishi; T Goya
Journal:  Thorac Cardiovasc Surg       Date:  2009-12       Impact factor: 1.827

7.  Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance.

Authors:  Wulf Sienel; Rita Seen-Hibler; Wolf Mutschler; Klaus Pantel; Bernward Passlick
Journal:  Eur J Cardiothorac Surg       Date:  2003-04       Impact factor: 4.191

8.  DNA methylation markers and early recurrence in stage I lung cancer.

Authors:  Malcolm V Brock; Craig M Hooker; Emi Ota-Machida; Yu Han; Mingzhou Guo; Stephen Ames; Sabine Glöckner; Steven Piantadosi; Edward Gabrielson; Genevieve Pridham; Kristen Pelosky; Steven A Belinsky; Stephen C Yang; Stephen B Baylin; James G Herman
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

9.  Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases.

Authors:  K Pantel; J Izbicki; B Passlick; M Angstwurm; K Häussinger; O Thetter; G Riethmüller
Journal:  Lancet       Date:  1996-03-09       Impact factor: 79.321

10.  Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas.

Authors:  Tetsukan Woo; Koji Okudela; Takuya Yazawa; Nobuyuki Wada; Nobuo Ogawa; Naoki Ishiwa; Michihiko Tajiri; Yasushi Rino; Hitoshi Kitamura; Munetaka Masuda
Journal:  Lung Cancer       Date:  2009-01-21       Impact factor: 5.705
View more
  2 in total

1.  Stereotactic ablative body radiation therapy or surgery for operable early non-small cell lung cancer patients: bound hand and foot to evidence.

Authors:  Antonin Levy; Olaf Mercier; Cécile Le Péchoux
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study.

Authors:  Erkan Topkan; Yurday Ozdemir; Ozan Cem Guler; Ahmet Kucuk; Ali Ayberk Besen; Huseyin Mertsoylu; Duygu Sezen; Eyub Yasar Akdemir; Ahmet Sezer; Yasemin Bolukbasi; Berrin Pehlivan; Ugur Selek
Journal:  J Oncol       Date:  2020-09-04       Impact factor: 4.375
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.